Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Cardiovascular and Cerebrovascular Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery

NCT00157716 is registered in ClinicalTrials.gov with Medicure as lead sponsor.

NCT NCT00157716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00157716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multi-Center Study to Evaluate the Cardiovascular and Cerebrovascular Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery
Lead sponsor
Medicure
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
October 31, 2005
Enrollment
900
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass graft surgery, myocardial ischemia, myocardial revascularization, reperfusion injury